Comparison of Pre- and Post-discharge Initiation of LCZ696 Therapy in HFrEF Patients After an Acute Decompensation Event

Clinical trial NCT02661217 · COMPLETED

Trial details

NCT number: NCT02661217
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Heart Failure With Reduced Ejection Fraction

Start date: 2016-02-12
Primary completion: 2018-02-20
Enrollment: 1002

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.